Efficacy of Intravenous versus Intramuscular Injection of Tramadol for Sickle Cell Vaso-occlusive Crisis
Not Applicable
- Conditions
- Health Condition 1: D570- Hb-SS disease with crisis
- Registration Number
- CTRI/2019/05/019359
- Lead Sponsor
- VIMSAR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1-diagnosed case of sickle cell disease with vaso-occlusive crisis both homozygous and compound hetrerozygous(by HPLC study)
2-VOC will be diagnosed if the patient present with pain involving skeleton, chest, abdomen or all three lasting 4hours or more.
3-moderate to severe grade of VOC (VISUAL ANALOGUE SCALE)
Exclusion Criteria
1- cases associated with diabetes mellitus, stroke, peripheral vascular disease, polycythemia that are likely to modify viscosity of blood.
2- contraindication for tramadol.
3- critically ill patients including acute chest syndrome.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method